title: [Molecular and cytometric analysis of renal cell carcinoma cells. Concepts, techniques and prospects].
abstract: At the present time, there is no reliable laboratory marker for the diagnosis and prognosis of clear cell renal cell carcinoma (RCC), while about 20% of small tumours detected by modern imaging techniques are benign and the clinical course is difficult to predict with considerable differences for the same stage and same grade. The molecular identification of clear cell RCC cells could satisfy these new requirements in the context of diagnosis of atypical or small renal tumours, allowing a more refined prognostic assessment, which is currently uncertain. Some of the antigens used for molecular diagnosis of clear cell RCC, such as cadherin-6, are present in the normal kidney, while others are newly formed antigens (TuM2PK, MN/CA9, CA12, calpain) or ectopic (PSMA, PSA, KLKI, cytokeratin 7 vimentin) or induce abnormal glycosylation (sialyl Lewis'X, galectins) indicating the malignant nature of the cells. The tumour's capacity for progression is related to dysregulations of the cycle (ras, Pax2, Tiam 1, waf/p21), division (tetracyclines, MIB1, PCNA, Nor Ag), apoptosis (bcl2, p53, CD95/Apo1), and the capacities for tissue invasion (proteases), disorganization (cadherin, catenins) or nidation (ICAM-1, CD44). Finally, chromosomal anomalies (mutations, translocations) also occur. MN/CA9, cadherin-6, vimentin, mucin 1 and DNA content are particularly useful for the diagnosis and/or prognosis of clear cell RCC. These markers can be analysed by extremely sensitive cytometric (flow cytometry, plate cytometry) or molecular methods (RT-PCR, in situ hybridization). These techniques lower the limit of detection of tumour cells in biological products (aspiration cytology, microbiopsy) and eventually in circulating blood. Proteomic and genomic methods (biochips) should considerably accelerate research in this field leading to the development of routine clinical applications.
authors.affiliation: Service d'Urologie-Andrologie, Hôpital Nord, Saint-Etienne, France.
authors.forename: Guorong
authors.initials: G
authors.lastname: Li
authors.forename: Claude
authors.initials: C
authors.lastname: Lambert
authors.forename: Anne
authors.initials: A
authors.lastname: Gentil-Perret
authors.forename: Christian
authors.initials: C
authors.lastname: Genin
authors.forename: Jacques
authors.initials: J
authors.lastname: Tostain
mesh_terms: D000951:Antigens, Neoplasm / Q000235:genetics; D002292:Carcinoma, Renal Cell / Q000175:diagnosis* / Q000235:genetics*; D006801:Humans; D007668:Kidney / Q000276:immunology; D007680:Kidney Neoplasms / Q000175:diagnosis* / Q000235:genetics*; D011379:Prognosis; D012016:Reference Values
chemical_list: D000951:Antigens, Neoplasm
vernacular_title: Analyse moléculaire et cytométrique des cellules d'adénocarcinome rénal. Concepts, techniques et perspectives.